Decibel Cannabis (DB) Stock Price, News & Analysis

Company Overview

Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada. It is also involved in the extraction, processing, and manufacturing vape cartridges, cannabis infused products, cannabis extracts, and glass tube packaging for pre-rolls. In addition, the company engages in the cannabis retail business through operating operational retail locations in Saskatchewan, as well as an e-commerce cannabis platform throughout the Province of Saskatchewan; and operational retail locations in Alberta. It offers its products under the Qwest, Vox, Blendcraft, and General Admission brands. Further, the company exports its products to Israel and Australia. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$1.53 to C$1.61
• 50-Day Range: C$0.11 to C$1.93
• 52-Week Range: C$1.35 to C$2.18
• Volume: 42,161 shs
• Average Volume: 20,178 shs
• Market Capitalization: C$61.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$1.93
• Consensus Rating: Strong Buy

Decibel Cannabis Stock Analysis - MarketRank™

Decibel Cannabis scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Decibel Cannabis has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Decibel Cannabis has a consensus price target of C$1.93, representing about 20.3% upside from its current price of C$1.60.

Amount of Analyst Coverage

Decibel Cannabis has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Decibel Cannabis is -10.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Decibel Cannabis is -10.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Decibel Cannabis has a P/B Ratio of 16.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DB.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Decibel Cannabis does not currently pay a dividend.

Dividend Growth

Decibel Cannabis does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.49

News Sentiment

Decibel Cannabis has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Decibel Cannabis this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for DB on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Decibel Cannabis insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.07% of the stock of Decibel Cannabis is held by insiders.

Percentage Held by Institutions

0.00% of the stock of Decibel Cannabis is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: CVE:DB
• CIK: N/A
• Web: www.decibelcc.com
• Phone: 587-664-0300
• Fax: N/A
• Employees: 83,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Decibel Cannabis: C$1.93
• High Price Target: C$3.75
• Low Price Target: C$0.10
• Potential Upside/Downside: +20.3%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.15)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 160.00
• P/E Growth: N/A
• Net Income: -C$1.03 million
• Net Margins: -3.78%
• Pretax Margin: N/A
• Return on Equity: -1.05%
• Return on Assets: 3.04%

Debt

• Debt-to-Equity Ratio: 107.39
• Current Ratio: 1.27
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$127.08 million
• Price / Sales: 0.48
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.10 per share
• Price / Book: 16.00

Miscellaneous

• Outstanding Shares: 38,470,000
• Free Float: N/A
• Market Cap: C$61.55 million
• Optionable: N/A
• Beta: 0.38